Visterra, Inc., a biotechnology company that uses its proprietary technology platform to identify unique disease targets and design novel therapeutics, today announced that it will present a corporate update at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2014, at 10:00 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco. The presentation will be delivered by Brian Pereira, M.D., President and CEO of Visterra, who will provide an update on the company’s therapeutic pipeline of novel antibodies for infectious diseases.
Help employers find you! Check out all the jobs and post your resume.
